Prenatal exposure to maternal fever during the second trimester raised odds of autism spectrum disorder by 40 percent, Mailman researchers found.
Columbia researchers have created a new mouse model of anorexia that may reveal new ways to treat the disorder.
The biomarker is an important step toward understanding and treating one of the most devastating symptoms of schizophrenia.
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.
Researchers from Columbia and the National Institute on Alcohol Abuse and Alcoholism have found that the number of Americans with marijuana use disorder has nearly doubled, but few get treatment.
Researchers have found that treatment with very low doses of a dopamine-1 receptor (D1R) agonist was not effective in reducing the cognitive and negative symptoms of schizophrenia.